Top Story

Ophthalmic community grieves Cesare Forlini, brilliant and tireless innovator of ocular surgery

Ophthalmic community grieves Cesare Forlini, brilliant and tireless innovator of ocular surgery
February 11, 2016

Cesare Forlini, MD, an internationally acclaimed vitreoretinal surgeon, passed away Feb. 9, ending what he himself defined as “a fierce fight in the mouth of the dragon.”

The former head of the trauma unit and ophthalmology department of Ravenna City Hospital, Italy, Forlini trained at the school of Prof. Egidio Dal Fiume, one of the pioneers of Italian ophthalmology, carrying forward his master’s vocation for complex and combined surgeries. His pole-to-pole “global strategy” and “multidistrict” approach to eye injuries, in which the surgeon moves between the anterior and posterior segment “like a dancer,” has become a paradigm in ocular traumatology and won him the 2013 Helen Keller Lecture at the American Academy of Ophthalmology meeting.

Business NewsFrom OSN APAO

Glaukos establishes direct sales organization, launches iStent inject in Australia

February 12, 2016
Glaukos has established a direct sales organization and launched the iStent inject trabecular micro-bypass stent in Australia, according to a press release. The iStent…

Senate health committee passes Next Generation Researchers Act

February 12, 2016
The Senate health committee passed the Next Generation Researchers Act (S. 2014) with bipartisan support on Tuesday, which aims to increase opportunities for young…
Breaking News

Senate: Health care IT bill will ‘end unfair practices’ for patients, providers

February 12, 2016
The U.S. Senate Committee on Health, Education, Labor and Pensions unanimously recommended a measure designed to improve health care information technology.The purpose…

BLOG: Practice efficiency — The adventures of Dr. Lycra, part 4

February 12, 2016
Three blog posts ago, we introduced you to Dr. Lycra, in the year 2066, and the innovations allowing future doctors to see vastly more patients. We continue and conclude…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Avoiding “Loss of Chance”… Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News CoverageVideo

VIDEO: FDA working with glaucoma community, patients in MIGS development

February 2, 2016
More »